Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

Phase 4

Completed

Conditions: Postoperative Pain

Interventions: Drug: Ketamine
Drug: Placebo

Registration Number: NCT04831736

Lead Sponsor: NYU Langone Health

Brief Summary: This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6mg/kg) of ketamine versus placebo (saline) on postoperative pain on adult women undergoing mastectomy.

The objective of the study is to examine the effect of a subanesthetic dose (0.6mg/kg) of ketamine vs. saline control on postoperative pain in subjects who have undergone mastectomy.

Detailed Description: Not available

Recruitment & Eligibility

Status: COMPLETED

Sex: Female

Target Recruitment: 31

Inclusion Criteria

Adult women, aged 18 to 80 years old, who will undergo mastectomy.
Willing to comply with all study procedures and be available for the duration of the study.
Will be scheduled for elective breast surgery for oncologic indication as follows: mastectomy +/- lymph node dissection, prophylactic mastectomy, unilateral or bilateral, with immediate reconstruction
No distant metastases.
Subject is American Society of Anesthesiologists (ASA) physical status 1, 2, or 3.
Subject is medically stable.

Exclusion Criteria

Cognitive impairment (by history) or clinical signs of altered mental status such as confusion, amnesia, disorientation, fluctuating levels of alertness, etc. that may interference with adherence to study procedures and/or participant safety.
Past ketamine or phencyclidine misuse or abuse.
Schizophrenia or history of psychosis.
Known sensitivity or allergy to ketamine.
Liver or renal insufficiency.
History of uncontrolled hypertension, chest pain, cardiac arrythmia, stroke, head trauma, intracranial mass or hemorrhage or pressure, glaucoma, acute globe injury, uncontrolled thyroid disease, porphyria, or any other contraindication to ketamine. Use of lamotrigine, alfentanil, physostigmine, and 4-aminopyridine are contraindicated
Pregnancy or nursing women
BMI>35.
Currently participating in another pain interventional trial.
Unwillingness to give informed consent.
Non-English speaking patients as QoR-15 and BCPQ have not been validated in all other languages

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment	Ketamine	-
Control	Placebo	-

Primary Outcome Measures

Name	Time	Method
Brief Pain Inventory-short Form (BPI) Pain Severity Subscale Score	48 Hours Post-Op (Day 3)	BPI Pain Severity Subscale consists of 4 questions (asking to rate pain). Each question is answered on a scale 0 (no pain) to 10 (pain as bad as you can imagine). The total range of score is 0-40; the higher the score, the worse the pain.

Secondary Outcome Measures

Name	Time	Method
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance (Short Form 6A) Score	Day 7 Post-Op (Day 8)	The PROMIS Sleep Disturbance Short Form consists of 6 items assessing sleep disturbance. Each question is answered with a score of 1-5 (varies). The raw score is the sum of each item and ranges from 6-30. The raw score is converted to a T-score ranging from 31.7 to 76.1, with a standard deviation of 10. Higher T-scores indicate greater sleep disturbance.
Generalized Anxiety Disorder (GAD-2) Score	Day 7 Post-Op (Day 8)	GAD-2 consists of 2 items and measures how often one has been bothered by anxiety-related problems. Each is answered with a score of 0 (not at all) to 3 (nearly every day). The total range of score is 0-6; the higher the score, the more frequent one is bothered by anxiety.
Quality of Recovery (QoR-15) Survey Score	Day 7 Post-Op (Day 8)	Part A of QoR-15 consists of 10 conditions. Based on how the patient has been feeling in the last 24 hours, they will respond to each condition using an 11-point Likert scale ranging from 0 to 10, where 0 is none of the time \[poor\] and 10 is all of the time \[excellent\]). The total range of score for Part A is 0-100; the higher the score, the better the participant has been feeling. Part B consists of 5 symptoms. The patient will indicate whether they have experienced each symptom over the last 24 hours using an 11-point Likert scale ranging from 10 to 0, where 10 is none of the time \[excellent\] and 0 is all of the time \[poor\]). The total range of score for Part B is 0-50; the higher the score, the better the participant has been feeling. The total score is the sum of of scores from Parts A and B. Scores range from 0-150; the higher the score, the better the participant has been feeling.
Number of Participants Who Experience Side Effects	Day 1 Post-Op (Day 2)	Side effects are calculated using a 7-item psycho-behavioral questionnaire. Participants indicate whether they have experienced any of the listed side effects. The side effects listed on the questionnaire are not considered to be Adverse Events or Serious Adverse Events.
Brief Pain Inventory-short Form (BPI) Pain Severity Subscale Score	Day 7 Post-Op (Day 8)	BPI Pain Severity Subscale is a 4-item questionnaire asking participants to rate pain. Each question is answered on a scale 0 (no pain) to 10 (pain as bad as you can imagine). The total range of score is 0-40; the higher the score, the worse the pain.
Brief Pain Inventory-short Form (BPI) Pain Interference Subscale Score	Day 7 Post-Op (Day 8)	BPI Pain Interference Subscale is a 7-item questionnaire asking participants to describe how pain has interfered during activities. Each question is answered on a scale 0 (does not interfere) to 10 (completely interferes). The total range of score is 0-70; the higher the score, the worse the interference.
Total Dosage of Opioid Use	Day 7 Post-Op (Day 8)	Use and dosage will be assess through medical records and subject reports.
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue (Short Form 7b) Daily Score	Day 7 Post-Op (Day 8)	The PROMIS Fatigue Short Form consists of 7 questions evaluating the frequency of fatigue. Each question is answered with a score from 1 (never) to 5 (always). The raw score is the sum of each item and ranges from 7-35. Raw scores are converted to T-scores ranging from 31 to 81.4, with a standard deviation of 10. Higher T-scores indicate higher frequency of fatigue.
Breast Cancer Pain Questionnaire (BCPQ) - Pain Score	Day 7 Post-Op (Day 8)	If the patient reports pain in the area of the breast, armpit, side of the body, or arm on the side of operation, the patient will be asked to report level of pain (0 is no pain and 10 is the worst pain imaginable). For each location, the total score is 0-10; the higher the score, the worse the pain. The total score is the sum of responses from each location.